Easton Capital
72
17M
47
2.88
21
0.35
20
- Stages of investment
- Areas of investment
Summary
Easton Capital appeared to be the VC, which was created in 1999. The leading representative office of defined VC is situated in the New York. The company was established in North America in United States.
The fund was created by John H. Friedman. We also calculated 4 valuable employees in our database.
The fund has specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Medical, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Biolex Therapeutics, Luminous Networks, Comprehend Systems Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Easton Capital, startups are often financed by Alta Partners, Rock Health, New Science Ventures. The meaningful sponsors for the fund in investment in the same round are New Science Ventures, Morgenthaler Ventures, Boston Millennia Partners. In the next rounds fund is usually obtained by TL Ventures, OrbiMed, New Science Ventures.
The important activity for fund was in 2007. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2006. Opposing the other organizations, this Easton Capital works on 10 percentage points less the average amount of lead investments. The typical startup value when the investment from Easton Capital is 10-50 millions dollars. The fund is constantly included in 2-6 deals per year. The real fund results show that this VC is 23 percentage points more often commits exit comparing to other companies.
Investments analytics
Analytics
- Total investments
- 72
- Lead investments
- 21
- Exits
- 20
- Rounds per year
- 2.88
- Follow on index
- 0.35
- Investments by industry
- Health Care (39)
- Biotechnology (22)
- Medical (22)
- Therapeutics (14)
- Medical Device (12) Show 61 more
- Investments by region
-
- United States (71)
- France (1)
- Peak activity year
- 2007
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 20M
- Group Appearance index
- 0.86
- Avg. company exit year
- 12
- Avg. multiplicator
- 0.75
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| electroCore | 30 Jun 2014 | Health Care, Medical Device, Therapeutics | Early Stage Venture | 55M | United States, New Jersey |
| PerceptiMed | 27 Mar 2015 | Health Care, Medical Device, Medical | Early Stage Venture | 5M | United States, California, Mountain View |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.